The year of 2023 for "Theragnostic Imaging"

The year 2023 has been an active and productive one for our research group, reflecting the collective efforts of our members and collaborators. We are pleased to report 17 publications in peer-reviewed journals, covering topics ranging from dosimetry in molecular radiotherapy to imaging optimization and clinical applications. These publications reflect the broad scope of our work and our commitment to advancing nuclear medicine physics.

Our team also had a strong presence at international conferences, delivering 14 presentations at international meetings such as EANM 2023, SNMMI 2023, and BiGART 2023. These included both invited talks and research presentations, addressing topics like theragnostic dosimetry, radiomic analysis, and clinical trial results. Members of our group also contributed to conference organization, serving on abstract committees and chairing multiple sessions.

This year also brought opportunities for mentorship and recognition. We supported early-career researchers through involvement in PhD defenses and master’s thesis evaluations. Notably, our group received the Clinical Paper of the Year award from Molecular Imaging and Biology, acknowledging our contributions to advancing imaging and treatment strategies in non-Hodgkin lymphoma. As the year ends, we look forward to continuing our collaborative efforts to improve diagnostic and therapeutic approaches in nuclear medicine.